{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:16:42Z","timestamp":1769023002639,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T00:00:00Z","timestamp":1553644800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00228-019-02670-9","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T19:50:22Z","timestamp":1553716222000},"page":"1135-1141","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement"],"prefix":"10.1007","volume":"75","author":[{"given":"Jennifer L.","family":"Goldman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Hung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian R.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Bing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfram","family":"Hoetzenecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Micheletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally Usdin","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Margolis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil H.","family":"Shear","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffery P","family":"Struewing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munir","family":"Pirmohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,27]]},"reference":[{"issue":"2","key":"2670_CR1","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jaci.2015.05.027","volume":"136","author":"LM Wheatley","year":"2015","unstructured":"Wheatley LM, Plaut M, Schwaninger JM, Banerji A, Castells M, Finkelman FD, Gleich GJ, Guttman-Yassky E, Mallal SA, Naisbitt DJ, Ostrov DA, Phillips EJ, Pichler WJ, Platts-Mills TA, Roujeau JC, Schwartz LB, Trepanier LA (2015) Report from the National Institute of Allergy and Infectious Diseases workshop on drug allergy. J Allergy Clin Immunol 136(2):262\u2013271 e262. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2015.05.027","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"2670_CR2","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","volume":"46","author":"G Danan","year":"1993","unstructured":"Danan G, Benichou C (1993) Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 46(11):1323\u20131330","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"2670_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/clpt.2009.252","volume":"88","author":"B Sassolas","year":"2010","unstructured":"Sassolas B, Haddad C, Mockenhaupt M, Dunant A, Liss Y, Bork K, Haustein UF, Vieluf D, Roujeau JC, Le Louet H (2010) ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: comparison with case-control analysis. Clin Pharmacol Ther 88(1):60\u201368. \n                    https:\/\/doi.org\/10.1038\/clpt.2009.252","journal-title":"Clin Pharmacol Ther"},{"issue":"12","key":"2670_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028096","volume":"6","author":"RM Gallagher","year":"2011","unstructured":"Gallagher RM, Kirkham JJ, Mason JR, Bird KA, Williamson PR, Nunn AJ, Turner MA, Smyth RL, Pirmohamed M (2011) Development and inter-rater reliability of the Liverpool adverse drug reaction causality assessment tool. PLoS One 6(12):e28096. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0028096","journal-title":"PLoS One"},{"issue":"2","key":"2670_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30(2):239\u2013245","journal-title":"Clin Pharmacol Ther"},{"issue":"12","key":"2670_CR6","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/pds.1138","volume":"14","author":"AF Macedo","year":"2005","unstructured":"Macedo AF, Marques FB, Ribeiro CF, Teixeira F (2005) Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel. Pharmacoepidemiol Drug Saf 14(12):885\u2013890. \n                    https:\/\/doi.org\/10.1002\/pds.1138","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2670_CR7","unstructured":"The RegiScar Project. (2018) \n                    http:\/\/www.regiscar.org\/cht\/index.html\n                    \n                  . Last accessed May 21, 2018"},{"issue":"1","key":"2670_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/cpt.1071","volume":"105","author":"YH Wang","year":"2018","unstructured":"Wang YH, Chen CB, Tassaneeyakul W, Saito Y, Aihara M, Choon SE, Lee HY, Chang MM, Roa FD, Wu CW, Zhang J, Nakkam N, Konyoung P, Okamoto-Uchida Y, Man-Tung Cheung C, Huang JW, Ji C, Cheng B, Chung-Yee Hui R, Chu CY, Chen YJ, Wu CY, Hsu CK, Chiu TM, Ho HC, Lin JY, Yang CH, Chang YC, Su SC, Wang CW, Chung WH, Asian Severe Cutaneous Adverse Reaction C (2018) The medication risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in Asians: the major drug causality and comparison to the USA FDA label. Clin Pharmacol Ther 105(1):112\u2013120. \n                    https:\/\/doi.org\/10.1002\/cpt.1071","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"2670_CR9","doi-asserted-by":"publisher","first-page":"276","DOI":"10.11613\/BM.2012.031","volume":"22","author":"ML McHugh","year":"2012","unstructured":"McHugh ML (2012) Interrater reliability: the kappa statistic. Biochem Med (Zagreb) 22(3):276\u2013282","journal-title":"Biochem Med (Zagreb)"},{"key":"2670_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/0471722146","volume-title":"Applied logistic regression","author":"DW Hosmer","year":"2000","unstructured":"Hosmer DW, Lemeshow S (2000) Applied logistic regression, 2nd edn. John Wiley & Sons, New York, NY","edition":"2"},{"issue":"1","key":"2670_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2165\/00002018-200831010-00003","volume":"31","author":"TB Agbabiaka","year":"2008","unstructured":"Agbabiaka TB, Savovic J, Ernst E (2008) Methods for causality assessment of adverse drug reactions: a systematic review. Drug Saf : Int J Med Toxicol Drug Experience 31(1):21\u201337","journal-title":"Drug Saf : Int J Med Toxicol Drug Experience"},{"issue":"11","key":"2670_CR12","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.2165\/11537780-000000000-00000","volume":"33","author":"H Theophile","year":"2010","unstructured":"Theophile H, Arimone Y, Miremont-Salame G, Moore N, Fourrier-Reglat A, Haramburu F, Begaud B (2010) Comparison of three methods (consensual expert judgement, algorithmic and probabilistic approaches) of causality assessment of adverse drug reactions: an assessment using reports made to a French pharmacovigilance centre. Drug safety : an international journal of medical toxicology and drug experience 33(11):1045\u20131054. \n                    https:\/\/doi.org\/10.2165\/11537780-000000000-00000","journal-title":"Drug safety : an international journal of medical toxicology and drug experience"},{"issue":"3","key":"2670_CR13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00228-004-0869-2","volume":"61","author":"Y Arimone","year":"2005","unstructured":"Arimone Y, Begaud B, Miremont-Salame G, Fourrier-Reglat A, Moore N, Molimard M, Haramburu F (2005) Agreement of expert judgment in causality assessment of adverse drug reactions. Eur J Clin Pharmacol 61(3):169\u2013173. \n                    https:\/\/doi.org\/10.1007\/s00228-004-0869-2","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"2670_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0171470","volume":"12","author":"FR Varallo","year":"2017","unstructured":"Varallo FR, Planeta CS, Herdeiro MT, Mastroianni PC (2017) Imputation of adverse drug reactions: causality assessment in hospitals. PLoS One 12(2):e0171470. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0171470","journal-title":"PLoS One"},{"issue":"5","key":"2670_CR15","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","volume":"29","author":"L Hazell","year":"2006","unstructured":"Hazell L, Shakir SA (2006) Under-reporting of adverse drug reactions : a systematic review. Drug Saf : Int J Med Toxicol Drug Experience 29(5):385\u2013396","journal-title":"Drug Saf : Int J Med Toxicol Drug Experience"},{"issue":"3","key":"2670_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024061","volume":"7","author":"RM Smyth","year":"2012","unstructured":"Smyth RM, Gargon E, Kirkham J, Cresswell L, Golder S, Smyth R, Williamson P (2012) Adverse drug reactions in children--a systematic review. PLoS One 7(3):e24061. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0024061","journal-title":"PLoS One"},{"issue":"1","key":"2670_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4103\/ijd.IJD_579_17","volume":"63","author":"S Pande","year":"2018","unstructured":"Pande S (2018) Causality or relatedness assessment in adverse drug reaction and its relevance in dermatology. Indian J Dermatol 63(1):18\u201321. \n                    https:\/\/doi.org\/10.4103\/ijd.IJD_579_17","journal-title":"Indian J Dermatol"},{"issue":"1","key":"2670_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40264-015-0367-8","volume":"39","author":"SL Collins","year":"2016","unstructured":"Collins SL, Carr DF, Pirmohamed M (2016) Advances in the pharmacogenomics of adverse drug reactions. Drug Saf : Int J Med Toxicol Drug Experience 39(1):15\u201327. \n                    https:\/\/doi.org\/10.1007\/s40264-015-0367-8","journal-title":"Drug Saf : Int J Med Toxicol Drug Experience"},{"issue":"1","key":"2670_CR19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1021\/acs.chemrestox.6b00357","volume":"30","author":"T Cho","year":"2017","unstructured":"Cho T, Uetrecht J (2017) How reactive metabolites induce an immune response that sometimes leads to an idiosyncratic drug reaction. Chem Res Toxicol 30(1):295\u2013314. \n                    https:\/\/doi.org\/10.1021\/acs.chemrestox.6b00357","journal-title":"Chem Res Toxicol"},{"issue":"1","key":"2670_CR20","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1021\/acs.chemrestox.6b00333","volume":"30","author":"MO Ogese","year":"2017","unstructured":"Ogese MO, Ahmed S, Alferivic A, Betts CJ, Dickinson A, Faulkner L, French N, Gibson A, Hirschfield GM, Kammuller M, Meng X, Martin SF, Musette P, Norris A, Pirmohamed M, Park BK, Purcell AW, Spraggs CF, Whritenour J, Naisbitt DJ (2017) New approaches to investigate drug-induced hypersensitivity. Chem Res Toxicol 30(1):239\u2013259. \n                    https:\/\/doi.org\/10.1021\/acs.chemrestox.6b00333","journal-title":"Chem Res Toxicol"}],"updated-by":[{"DOI":"10.1007\/s00228-019-02710-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T00:00:00Z","timestamp":1561766400000}}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02670-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-019-02670-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02670-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T00:14:54Z","timestamp":1585181694000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-019-02670-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,27]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["2670"],"URL":"https:\/\/doi.org\/10.1007\/s00228-019-02670-9","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00228-019-02710-4","asserted-by":"object"}]},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,27]]},"assertion":[{"value":"31 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The correct name of the 9th Author is David J. Margolis. The original article was corrected.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Since the data received by the SJS\/TEN Standardizing Case Definitions Working Group was de-identified and no potentially identifiable variables were provided, no ethical approval was needed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}